Safety and Tolerance Study of Oral Doses of CT53518 to Treat Patients With Acute Myelogenous Leukemia (AML)

This study has been completed.

Study NCT00064584 Information provided by Millennium Pharmaceuticals, Inc.

First Received: July 9, 2003 Last Updated: March 23, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	July 2005
Primary Completion Date:	January 2005 (Final data collection date for primary outcome measure)